ThePlottingPanda t1_ixvfdko wrote on November 26, 2022 at 6:04 PM Reply to Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial by Sorin61 The current standard of care has only 5% of patients surviving past five years, and this vaccine allows 13%. That nearly triples the rate of survival, however small. Definitely hopeful stuff! Permalink 307
ThePlottingPanda t1_ixvfdko wrote
Reply to Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial by Sorin61
The current standard of care has only 5% of patients surviving past five years, and this vaccine allows 13%. That nearly triples the rate of survival, however small.
Definitely hopeful stuff!